![Devin Blass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 340 871 $ as of 30/05/2026
Mr. Devin Blass is a Chief Technology Officer & Senior Vice President at Longeveron, Inc. Mr. Blass was previously employed as a Senior Vice President-Comprehensive Cell Solutions by New York Blood Center, Inc., a Vice President-Technical Operations by Talaris Therapeutics, Inc., a Head-Cell Manufacturing Operations by Bellicum Pharmaceuticals, Inc., and a Director-Commercial Program Manufacturing by Mesoblast, Inc. He received his undergraduate degree from Texas State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/04/2026 | 441,543 ( 1.46% ) | 340 871 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| LONGEVERON INC. | Chief Tech/Sci/R&D Officer | 01/12/2024 |
| Companies | Position | End |
|---|---|---|
New York Blood Center, Inc.
 New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Corporate Officer/Principal | - |
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Corporate Officer/Principal | - |
| TOUE BIOPAR | Chief Operating Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 6 |
|---|---|
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Health Services |
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Texas State University
 Texas State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Longeveron, Inc.
 Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
